The life sciences industry – pharmaceuticals, medical devices, diagnostics, vaccines and related businesses – is huge, growing and global, with international licensing, sales contracts, research and development agreements, and joint ventures.

发言人:: James P. Duffy IV

活动类型: 研讨会

Charles River Associates, 200 Clarendon Street, Floor 9 , Boston MA
10 April 2019
10 April 2019

Each of these international ventures can lead to disputes, and well-positioned life sciences companies prefer international arbitration to litigation as the practical way to achieve confidential, widely enforceable judgments in a neutral setting.

Listen in as our distinguished panel of speakers explain why international arbitration is the preferred dispute resolution mechanism for life sciences disputes, before they take a deeper dive into some of the complex issues that can arise in such disputes.